Key stats
About Ark Genomic Revolution Ucits ETF AccumUSD
Home page
Inception date
Apr 12, 2024
Replication method
Synthetic
Dividend treatment
Capitalizes
Primary advisor
ARK Investment Management LLC
ISIN
IE000O5M6XO1
The investment objective of the Fund is to generate long term capital growth (5 years or more)
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Health Services
Technology Services
Stocks99.70%
Health Technology71.67%
Health Services14.65%
Technology Services13.38%
Bonds, Cash & Other0.30%
Cash0.30%
Stock breakdown by region
North America89.09%
Europe10.91%
Latin America0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
ARKG invests in stocks. The fund's major sectors are Health Technology, with 71.67% stocks, and Health Services, with 14.65% of the basket. The assets are mostly located in the North America region.
ARKG top holdings are CRISPR Therapeutics AG and Tempus AI, Inc. Class A, occupying 8.21% and 8.21% of the portfolio correspondingly.
ARKG assets under management is 35.33 M CHF. It's risen 60.85% over the last month.
ARKG fund flows account for 28.63 M CHF (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, ARKG doesn't pay dividends to its holders.
ARKG shares are issued by ARK Investment Management LP under the brand ARK. The ETF was launched on Apr 12, 2024, and its management style is Active.
ARKG expense ratio is 0.79% meaning you'd have to pay 0.79% of your investment to help manage the fund.
ARKG follows the No Underlying Index. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
ARKG invests in stocks.
ARKG price has risen by 11.90% over the last month, and its yearly performance shows a 14.98% increase. See more dynamics on ARKG price chart.
NAV returns, another gauge of an ETF dynamics, have risen by 9.50% over the last month, showed a 19.09% increase in three-month performance and has increased by 11.40% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by 9.50% over the last month, showed a 19.09% increase in three-month performance and has increased by 11.40% in a year.
ARKG trades at a premium (1.31%) meaning the ETF is trading at a higher price than the calculated NAV.